13th Expert Meeting for Pediatric Oncology and Hematology

Abstracts (HTML) Autorenliste

Aryee, D

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Astrahantseff, K

Molecular Targets in Embryonal Tumors

Bader, P

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Ban, J

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Benetkiewicz, M

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Berthold, F

Novel Targeted Agents in Neuroblastoma

Binder, V

Hsa-mir-125b-2 is Highly Expressed in Childhood ETV6/RUNX1 (TEL/AML1) Leukemias and Confers Survival Advantage to Growth Inhibitory Signals Independent of P53

Borkhardt, A

The Expanding Family of ALK-Mediated Malignancies in Childhood

Bourquin, JP

Xenotransplantation in Immunodeficient Mice to Evaluate New Therapeutic Strategies for Refractory Childhood Acute Lymphoblastic Leukemia
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Breit, S

The Role of Activated NOTCH Signaling in Childhood T-ALL

Breithaupt, P

Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Brown, R

Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience

Bueren, AO von

Molecular-Targeted Therapies for Childhood Medulloblastoma

Burdach, S

Targeting Epigenetic Maintenance of Stemness in Pediatric Malignancy

Cam, H

Dysregulation of mTORC1 Signaling in Childhood Solid Tumors

Cario, G

Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Caron, HN

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Clifford, S

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Clifford, SC

The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Conter, V

Clinical Goals of Targeted Therapy in Childhood ALL

Corbacioglu, S

The RIST Strategy: Molecular-Based Multimodal Treatment Regimens in Pediatric Oncology

Debatin, KM

Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups
Cell Death Pathways: Sensitivity and Resistance in Leukemia
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Degrand, O

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

De Jong, S

Targeting TRAIL Death Receptors: TRAIL from the Lab to the Clinic

Delattre, O

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Den Boer, M

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Den Boer, ML

The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Deubzer, H

Targeting HDACs in Pediatric Oncology

De Vries, EGE

Targeting TRAIL Death Receptors: TRAIL from the Lab to the Clinic

Ecke, I

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Eckhoff, SM

Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups

Eggert, A

Molecular Targets in Embryonal Tumors

Ehrhardt, H

NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs

Fakler, M

Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Fischer, M

Novel Targeted Agents in Neuroblastoma

Fulda, S

Targeting Apoptosis Pathways for the Treatment of Pediatric Cancers
Editorial
Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia
Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Geoerger, B

Innovative Therapies for Children with Cancer (ITCC): Clinical Trial Program
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Gombert, M

High-Throughput Mutation Analysis of Tyrosine Kinome in Childhood AML

Hahn, H

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Helman, LJ

Targeting the IGF1 Pathway in Pediatric Sarcomas

Herold, R

Regulatory and Scientific Support for Developing Innovative Medicines for Children with Cancer

Höfig, I

NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs

Holst, M

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Houghton, PJ

Development of Novel Therapy for Childhood Cancer: Promise and Challenges
Dysregulation of mTORC1 Signaling in Childhood Solid Tumors

Jaeger, BAS

Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)

Jeremias, I

Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis
NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs

Jug, G

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Kappler, R

The Hedgehog Signaling Pathway as a Therapeutic Target in Pediatric Liver Tumors

Kauer, M

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Klingebiel, T

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Koehl, U

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Kool, M

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Kovar, H

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Kox, C

The Role of Activated NOTCH Signaling in Childhood T-ALL

Kreyenberg, H

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Kuçi, S

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Kuçi, Z

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Kulozik, AE

The Role of Activated NOTCH Signaling in Childhood T-ALL

Künkele, A

Molecular Targets in Embryonal Tumors

Lanvers, C

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Letai, A

BH3 Profiling – A Predictive Biomarker for Apoptotic Response to Chemotherapy

Löder, S

Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Mann, G

Clinical Goals of Targeted Therapy in Childhood ALL

Meissner, B

Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Mesdagh, P

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Meyer, LH

Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups

Milde, T

Targeting HDACs in Pediatric Oncology

Molenaar, JJ

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Möricke, A

Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Muckenthaler, MU

The Role of Activated NOTCH Signaling in Childhood T-ALL

Niedan, S

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Nitzki, F

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Obexer, P

NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs

Oehme, I

Targeting HDACs in Pediatric Oncology

Pajtler, K

Molecular Targets in Embryonal Tumors

Pfister, S

Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience
Potential of Molecular Targeted Therapies in Childhood Brain Tumors (BRAF Inhibitors)

Pieters, R

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Pietsch, T

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Poremba, C

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Potratz, J

RNA Interference Screening to Identify Novel Therapeutic Targets

Queudeville, M

Single-cell Phospho-Profiling in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Reveals Signaling Differences in Cytogenetic and Prognostic Subgroups

Raymond, AS

Regulatory and Scientific Support for Developing Innovative Medicines for Children with Cancer

Remke, M

The Role of Activated NOTCH Signaling in Childhood T-ALL

Renshaw, J

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Rettinger, E

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Ritter, J

The Etiology of Acute Childhood Leukemias

Rosenberger, A

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Rosen-Wolff, A

Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)

Rutkowski, S

Molecular-Targeted Therapies for Childhood Medulloblastoma

Schäfer, BW

Therapeutic Strategies Targeting Oncogenic Fusion Proteins in Sarcomas

Schneider, K

Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Schramm, A

Molecular Targets in Embryonal Tumors

Schrappe, M

The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Schrauder, A

Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Schulte, JH

Lysine-Specific Demethylase 1 is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy
Molecular Targets in Embryonal Tumors

Schulz-Schaeffer, W

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Scotlandi, K

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Segers, S

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Serra, M

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Shipley, J

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Sorensen, P

RNA Interference Screening to Identify Novel Therapeutic Targets
Tyrosine Kinase Networks in Pediatric Cancer

Speleman, F

The "Ideal" Target's Network: Factors Modulating EWS-FLI1 Expression and Function in Ewing's Sarcoma

Stanulla, M

The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL
Early Diagnosis and Targeted Treatment of Very High-Risk Childhood Acute Lymphoblastic Leukemia – The I-BFM Approach

Stroeken, PJ

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Suttorp, M

Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)

Tauer, JT

Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)

Terziyska, N

NOXA as Target for the Combination Therapy of Betulinic Acid and Conventional Cytotoxic Drugs

Thall, P

Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience

Uhmann, A

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Valsecchi, MG

Clinical Goals of Targeted Therapy in Childhood ALL

Vassal, G

Innovative Therapies for Children with Cancer (ITCC): Clinical Trial Program
The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Verschuur, AC

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Versteeg, R

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Vogler, M

Targeting IAP Proteins to Sensitize Childhood Acute Leukemia Cells for Apoptosis

Von Laer, D

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Warps, R

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers

Weber, G

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Westerhout, EM

The KidsCancerKinome – Validation of Drug Targets for High Risk Childhood Cancers
The KidsCancerKinome: Validation of Cell Cycle Genes as Potential Drug Targets in Pediatric Tumors

Willasch, A

Enhancing Cytotoxicity of Cytokine-Induced Killer (CIK) Cells against Refractory Leukemia

Witt, O

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?
Targeting HDACs in Pediatric Oncology

Wolff, JE

Personalized Targeted Therapy for Refractory Pediatric Brain Tumors Program: Concept and Preliminary Clinical Experience

Zibat, A

Hedgehog Signaling: A Therapeutic Target in Embryonal Rhabdomyosarcoma?

Zimmermann, M

The Role of Activated NOTCH Signaling in Childhood T-ALL
Clinical Goals of Targeted Therapy in Childhood ALL